Cargando…

Identification of an EMT-related lncRNA signature and LINC01116 as an immune-related oncogene in hepatocellular carcinoma

Background: Epithelial–mesenchymal transition (EMT) plays a critical role in the recurrence and metastasis of hepatocellular carcinoma (HCC). Some long noncoding (lnc)RNAs are involved in this process through the regulation of EMT-related transcription factors. Methods: In this study, we established...

Descripción completa

Detalles Bibliográficos
Autores principales: Tao, Haisu, Zhang, Yuxin, Yuan, Tong, Li, Jiang, Liu, Junjie, Xiong, Yixiao, Zhu, Jinghan, Huang, Zhiyong, Wang, Ping, Liang, Huifang, Zhang, Erlei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8876905/
https://www.ncbi.nlm.nih.gov/pubmed/35148283
http://dx.doi.org/10.18632/aging.203888
_version_ 1784658280830730240
author Tao, Haisu
Zhang, Yuxin
Yuan, Tong
Li, Jiang
Liu, Junjie
Xiong, Yixiao
Zhu, Jinghan
Huang, Zhiyong
Wang, Ping
Liang, Huifang
Zhang, Erlei
author_facet Tao, Haisu
Zhang, Yuxin
Yuan, Tong
Li, Jiang
Liu, Junjie
Xiong, Yixiao
Zhu, Jinghan
Huang, Zhiyong
Wang, Ping
Liang, Huifang
Zhang, Erlei
author_sort Tao, Haisu
collection PubMed
description Background: Epithelial–mesenchymal transition (EMT) plays a critical role in the recurrence and metastasis of hepatocellular carcinoma (HCC). Some long noncoding (lnc)RNAs are involved in this process through the regulation of EMT-related transcription factors. Methods: In this study, we established a novel EMT-related lncRNA signature in HCC and identified hub lncRNAs that can serve as potential therapeutic targets. Differentially expressed lncRNAs were identified by screening HCC patient data from The Cancer Genome Atlas, and a correlation analysis was performed to identify those associated with EMT. The EMT-related lncRNA signature was established by univariate, least absolute shrinkage and selection operator, and multivariate Cox regression analyses. After verifying the prognostic accuracy of the signature, its relationships to immune cell infiltration and immune checkpoint targets were explored. LINC01116 was identified as a hub lncRNA and its role in HCC was investigated in vitro and in vivo. Results: A 5-lncRNA signature was developed for HCC and its prognostic accuracy was assessed by survival, time-dependent receiver operating characteristic curve, clinical correlation, and Cox regression analyses. The correlation analysis showed that the lncRNA signature was closely related to immune cell infiltration and 10 immune checkpoint targets and also predicted the prognosis of HCC patients with high accuracy. In vitro and in vivo experiments revealed that LINC01116 stimulated cell proliferation, cell cycle progression, and tumor metastasis. We also found that LINC01116 was closely related to immune regulation. Conclusions: These results demonstrate that LINC01116 is an immune-related oncogene that is associated with both EMT and immune regulation in HCC. Moreover, the EMT-related lncRNA signature that includes LINC01116 can guide risk stratification and clinical decision-making in HCC management.
format Online
Article
Text
id pubmed-8876905
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Impact Journals
record_format MEDLINE/PubMed
spelling pubmed-88769052022-03-01 Identification of an EMT-related lncRNA signature and LINC01116 as an immune-related oncogene in hepatocellular carcinoma Tao, Haisu Zhang, Yuxin Yuan, Tong Li, Jiang Liu, Junjie Xiong, Yixiao Zhu, Jinghan Huang, Zhiyong Wang, Ping Liang, Huifang Zhang, Erlei Aging (Albany NY) Research Paper Background: Epithelial–mesenchymal transition (EMT) plays a critical role in the recurrence and metastasis of hepatocellular carcinoma (HCC). Some long noncoding (lnc)RNAs are involved in this process through the regulation of EMT-related transcription factors. Methods: In this study, we established a novel EMT-related lncRNA signature in HCC and identified hub lncRNAs that can serve as potential therapeutic targets. Differentially expressed lncRNAs were identified by screening HCC patient data from The Cancer Genome Atlas, and a correlation analysis was performed to identify those associated with EMT. The EMT-related lncRNA signature was established by univariate, least absolute shrinkage and selection operator, and multivariate Cox regression analyses. After verifying the prognostic accuracy of the signature, its relationships to immune cell infiltration and immune checkpoint targets were explored. LINC01116 was identified as a hub lncRNA and its role in HCC was investigated in vitro and in vivo. Results: A 5-lncRNA signature was developed for HCC and its prognostic accuracy was assessed by survival, time-dependent receiver operating characteristic curve, clinical correlation, and Cox regression analyses. The correlation analysis showed that the lncRNA signature was closely related to immune cell infiltration and 10 immune checkpoint targets and also predicted the prognosis of HCC patients with high accuracy. In vitro and in vivo experiments revealed that LINC01116 stimulated cell proliferation, cell cycle progression, and tumor metastasis. We also found that LINC01116 was closely related to immune regulation. Conclusions: These results demonstrate that LINC01116 is an immune-related oncogene that is associated with both EMT and immune regulation in HCC. Moreover, the EMT-related lncRNA signature that includes LINC01116 can guide risk stratification and clinical decision-making in HCC management. Impact Journals 2022-02-11 /pmc/articles/PMC8876905/ /pubmed/35148283 http://dx.doi.org/10.18632/aging.203888 Text en Copyright: © 2022 Tao et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/3.0/) (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Paper
Tao, Haisu
Zhang, Yuxin
Yuan, Tong
Li, Jiang
Liu, Junjie
Xiong, Yixiao
Zhu, Jinghan
Huang, Zhiyong
Wang, Ping
Liang, Huifang
Zhang, Erlei
Identification of an EMT-related lncRNA signature and LINC01116 as an immune-related oncogene in hepatocellular carcinoma
title Identification of an EMT-related lncRNA signature and LINC01116 as an immune-related oncogene in hepatocellular carcinoma
title_full Identification of an EMT-related lncRNA signature and LINC01116 as an immune-related oncogene in hepatocellular carcinoma
title_fullStr Identification of an EMT-related lncRNA signature and LINC01116 as an immune-related oncogene in hepatocellular carcinoma
title_full_unstemmed Identification of an EMT-related lncRNA signature and LINC01116 as an immune-related oncogene in hepatocellular carcinoma
title_short Identification of an EMT-related lncRNA signature and LINC01116 as an immune-related oncogene in hepatocellular carcinoma
title_sort identification of an emt-related lncrna signature and linc01116 as an immune-related oncogene in hepatocellular carcinoma
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8876905/
https://www.ncbi.nlm.nih.gov/pubmed/35148283
http://dx.doi.org/10.18632/aging.203888
work_keys_str_mv AT taohaisu identificationofanemtrelatedlncrnasignatureandlinc01116asanimmunerelatedoncogeneinhepatocellularcarcinoma
AT zhangyuxin identificationofanemtrelatedlncrnasignatureandlinc01116asanimmunerelatedoncogeneinhepatocellularcarcinoma
AT yuantong identificationofanemtrelatedlncrnasignatureandlinc01116asanimmunerelatedoncogeneinhepatocellularcarcinoma
AT lijiang identificationofanemtrelatedlncrnasignatureandlinc01116asanimmunerelatedoncogeneinhepatocellularcarcinoma
AT liujunjie identificationofanemtrelatedlncrnasignatureandlinc01116asanimmunerelatedoncogeneinhepatocellularcarcinoma
AT xiongyixiao identificationofanemtrelatedlncrnasignatureandlinc01116asanimmunerelatedoncogeneinhepatocellularcarcinoma
AT zhujinghan identificationofanemtrelatedlncrnasignatureandlinc01116asanimmunerelatedoncogeneinhepatocellularcarcinoma
AT huangzhiyong identificationofanemtrelatedlncrnasignatureandlinc01116asanimmunerelatedoncogeneinhepatocellularcarcinoma
AT wangping identificationofanemtrelatedlncrnasignatureandlinc01116asanimmunerelatedoncogeneinhepatocellularcarcinoma
AT lianghuifang identificationofanemtrelatedlncrnasignatureandlinc01116asanimmunerelatedoncogeneinhepatocellularcarcinoma
AT zhangerlei identificationofanemtrelatedlncrnasignatureandlinc01116asanimmunerelatedoncogeneinhepatocellularcarcinoma